A closer look at the middlemen in the distribution of insulin (IMAGE)
Caption
Several middlemen take a share of the savings on insulin that are offered by drug manufacturers, though the savings are intended to help patients and lower the overall costs.
Credit
USC Schaeffer Center
Usage Restrictions
Credit USC Schaeffer Center
License
Original content